China Universal Asset Management Company’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Sell |
84,631
-2,287
| -3% | -$82.4K | 0.29% | 70 |
|
|
2025
Q1 | $2.71M | Sell |
86,918
-7,290
| -8% | -$227K | 0.25% | 88 |
|
|
2024
Q4 | $2.4M | Buy |
94,208
+8,018
| +9% | +$205K | 0.22% | 92 |
|
|
2024
Q3 | $2.44M | Buy |
86,190
+33,206
| +63% | +$939K | 0.27% | 79 |
|
|
2024
Q2 | $1.4M | Sell |
52,984
-32,895
| -38% | -$867K | 0.2% | 89 |
|
|
2024
Q1 | $2.61M | Buy |
85,879
+34,207
| +66% | +$1.04M | 0.33% | 65 |
|
|
2023
Q4 | $1.45M | Buy |
51,672
+40,149
| +348% | +$1.13M | 0.28% | 83 |
|
|
2023
Q3 | $313K | Buy |
11,523
+5,649
| +96% | +$153K | 0.09% | 122 |
|
|
2023
Q2 | $181K | Sell |
5,874
-131
| -2% | -$4.03K | 0.06% | 135 |
|
|
2023
Q1 | $216K | Buy |
6,005
+1,524
| +34% | +$54.9K | 0.07% | 114 |
|
|
2022
Q4 | $177K | Buy |
4,481
+388
| +9% | +$15.3K | 0.07% | 107 |
|
|
2022
Q3 | $164K | Buy |
+4,093
| New | +$164K | 0.07% | 99 |
|